Overview

From the town of Isafjordur in northwest Iceland, Kerecis develops, manufactures, and sells patented fish-skin soft tissue regeneration products that have regulatory approval in the United States, Europe and several other jurisdictions.

We provide our customers with innovative digital tools for managing their business, including artificial intelligence (AI) to support insurance billing.

We have regional headquarters in the United States, Iceland, and Germany with more than 620 employees including a 260-person US salesforce.

Kerecis is part of Coloplast A/S.

Kerecis is actively working on expanding its portfolio within the company’s current segments, from operating rooms to outpatient settings. Our product offerings include intact fish skin for wound healing (MariGen and Shield), intact fish skin for operating room success (SurgiClose and SurgiBind), intact fish skin for burn healing (GraftGuide), and intact fish skin for animal care (Kerecis VET). The Kerecis products classify as medical devices.

Products are available in sheets that are either solid, fenestrated or meshed. Micro is intact fish skin that we fragment into tiny particles that can be rehydrated and inserted or poured directly into wounds that are complex or irregular.

The Kerecis Current platform, powered by artificial intelligence (AI), allows providers to submit and track benefits investigation cases, product orders, and invoices in real time. This reduces the need for phone calls, faxing, or outdated systems. Similarly, our Workspace application gives our sales team real-time access to company tools, helping them work more efficiently.